Johnson Investment Counsel Inc Moderna, Inc. Transaction History

Johnson Investment Counsel Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$135.66 - $197.02 $191,823 - $278,586	1,414 Added 70.03%	3,433 $527,000
Q4 2022 Feb 14, 2023	SELL	$118.38 - $210.04 $12,193 - $21,634	-103 Reduced 4.85%	2,019 $362,000
Q3 2022 Nov 14, 2022	BUY	$118.07 - $194.18 $11,688 - $19,223	99 Added 4.89%	2,122 $251,000
Q1 2022 May 11, 2022	SELL	$126.46 - $235.05 $128,736 - $239,280	-1,018 Reduced 33.48%	2,023 $348,000
Q4 2021 Feb 15, 2022	BUY	$225.82 - $368.51 $24,162 - $39,430	107 Added 3.65%	3,041 $772,000
Q3 2021 Nov 12, 2021	BUY	$221.9 - $484.47 $23,077 - $50,384	104 Added 3.67%	2,934 $1.13 Million
Q2 2021 Aug 13, 2021	SELL	$129.91 - $234.98 $1,948 - $3,524	-15 Reduced 0.53%	2,830 $665,000
Q1 2021 May 14, 2021	BUY	$109.18 - $185.98 $16,377 - $27,897	150 Added 5.57%	2,845 $373,000
Q4 2020 Feb 12, 2021	SELL	$65.74 - $169.86 $143,641 - $371,144	-2,185 Reduced 44.77%	2,695 $282,000
Q3 2020 Nov 16, 2020	BUY	$54.34 - $94.85 $265,179 - $462,868	4,880 New	4,880 $345,000

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Johnson Investment Counsel Inc, based on Form 13F filings with the SEC.

Stay updated on Johnson Investment Counsel Inc with notifications on news.